Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Marvel Biosciences Corp.
No Price
Closing Price XTSX 01.05.2026:
0,17 CAD
01.05.2026 19:59
Current Prices from Marvel Biosciences Corp.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
TSX-V
MRVL.V
CAD
01.05.2026 19:59
0,17 CAD
-0,005 CAD
-2,94 %
Share Float & Liquidity
Free Float81,74 %
Shares Float51,52 M
Shares Outstanding63,03 M
Company Profile for Marvel Biosciences Corp. Share
Marvel Biosciences Corp. operates as a pre-clinical stage pharmaceutical development biotechnology company. It engages in the discovery and development of synthetic derivative compounds of known drugs that inhibit the A2a adenosine receptor. The company offers Nourianz (Istradefylline, KW-6002) and MB-204 an adenosine A2A receptor antagonist. It targets neurological diseases, such as Alzheimer's disease, depression and anxiety, and non-neurological conditions of cancer; and non-alcoholic steatohepatitis. Marvel Biosciences Corp. is headquartered in Calgary, Canada.
